2021-003790-65: Clinical study to compare the therapeutic effects of two ointments with the active substances clotrimazole and betamethasone dipropionate and of one ointment without active substance for patients with moderate to severely inflamed infection of the skin through yeast fungi. |
|
|
| Not yet recruiting | 3 | 552 | Europe | Mecloderm Ointment, Lotricomb ointment, Ointment, Lotricomb® Salbe | Dermapharm AG, Dermapharm AG | moderate to severely inflamed candidiasis of the skin, moderate to severely inflamed infection of the skin through yeast fungi, Diseases [C] - Skin and Connective Tissue Diseases [C17] | | | | |
